Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Ivim Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Ivim Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 359 · Grade C

Ivim Health

Visit Ivim Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Ivim Health a bad call — it's best for people considering longer-term care who can keep required membership active and understand the medication-access period and refund deductions. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
34
Supply Reliability
95
74
Transparency
90
64
Access Breadth
93
50
Clinical Oversight
92
79
Track Record
88
73
CoreAge RxBrief Score 94 · 60Ivim Health

Price, coverage & the tracker

CoreAge RxIvim Health
Brief Score94/100 (A)60/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Advertised from $65/month + membership

Twelve-month medication offer; full selected payment unconfirmed. Required care: $74.99/month. First-month-free care promotion needs eligibility confirmation.

Active membership and required check-ins govern shipments. Confirm the twelve-month refund terms; the review explains the plan-specific cancellation rules.

Full price details

Compounded semaglutide weekly injection offered; complete selected-program quote unknown; advertised from $65/month on a homepage twelve-month offer, plus required $74.99/month membership; full medication payment unconfirmed

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Advertised from $117/month + membership

Twelve-month medication offer; full selected payment unconfirmed. Required care: $74.99/month. First-month-free care promotion needs eligibility confirmation.

Active membership and required check-ins govern shipments. Confirm the twelve-month refund terms; the review explains the plan-specific cancellation rules.

Full price details

Compounded tirzepatide weekly injection offered; complete selected-program quote unknown; advertised from $117/month on a homepage twelve-month offer, plus required $74.99/month membership; full medication payment unconfirmed

CoverageUS only; restrictions by state, confirmed at intakeTreatment requires provider approval and lawful patient-location access; a complete current medication-specific state list was not established on reviewed pages
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Ivim Health: Medication offers from $65/$117 monthly are tied to twelve months; required membership is $74.99/month extra. Confirm full payment, access period and cancellation deductions before purchase.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.